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SummARy – in colorectal carcinoma, carcinoembryonic antigen (CEA) is a recommended 
marker for surveillance after curative resection. The aim of the present study was to determine the as-
sociation of preoperative CEA with recurrence of colorectal carcinoma in our population. The study 
included 55 patients with all operable stages of colorectal adenocarcinoma treated during the 2012-
2014 period, evaluated retrospectively and followed-up for recurrence for 2 years. Data on the baseline 
(preoperative) CEA levels were retrieved from patient files. On data analysis, SPSS 16.0 was used. in 
patients with normal preoperative CEA, the rate of recurrence was significantly low (p=0.008) and the 
likelihood of no recurrence 1.55-fold greater as compared to patients with raised initial CEA levels 
(p=0.028). in patients with raised preoperative CEA, the risk of recurrence was 5.26-fold greater as 
compared to those with normal CEA levels (p=0.028). A significant weak positive correlation 
(rs=0.297) was found between raised CEA and recurrence. A highly significant (p=0.002) moderate 
positive correlation was recorded in patients aged <50 and moderate positive correlation of borderline 
significance in males (rs=0.324, p=0.058). Sensitivity was 94.4% and specificity 32.4% in predicting 
recurrence. Accordingly, preoperative elevated CEA showed a significant weak positive correlation 
with recurrence while normal preoperative CEA moderately decreased the likelihood of recurrence.
Key words: Carcinoembryonic antigen; Colorectal neoplasm; Prognosis; Recurrence; Risk
Correspondence to: Ismat Fatima, PhD, institute of nuclear medi-
cine and Oncology, lahore, Pakistan
E-mail: drismatfatima14@gmail.com
Received march 13, 2018, accepted September 26, 2019
Introduction
Colorectal carcinoma (CRC) is the third most 
common cancer in the world and second leading cause 
of death due to cancer1. in CRC, carcinoembryonic 
antigen (CEA) is a recommended marker for surveil-
lance after curative resection2,3. it is the only reliable 
serum marker during follow up and consistent elevat-
ed CEA is an alarming sign of recurrent disease4. Pre-
operative elevated CEA has also been associated with 
poor prognosis and recurrence. many current studies 
have strongly recommended its addition in current 
staging system for CRC. its role in treatment planning 
of patients undergoing curative resection is being 
studied extensively. The role of normal CEA levels in 
ruling out the possibility of either primary or recurrent 
CRC is also under consideration5-8.
The aim of the present study was to correlate pre-
operative CEA levels with recurrence in our local set-
ting. its variance with age, gender, stage and grade of 
disease was also studied.
Patients and Methods
it was a descriptive case series. Study population 
comprised diagnosed CRC patients registered in our 
hospital during the 2012-2014 period and meeting the 
inclusion criteria. Ethical approval from the institu-
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tional review board was obtained prior to the study. it 
was a retrospective study, so patient consent was not 
required. Patients with all operable stages of colorectal 
adenocarcinoma and histopathologically proven 
colorectal adenocarcinoma with preoperative serum 
CEA levels recorded were included. Exclusion criteria 
were pregnancy and secondary malignancy.
Data were collected from archival case files of pa-
tients. Patients who did not present for follow up visit 
for at least two years after treatment were excluded. 
Patients that met the selection criteria and had pre-
sented for regular follow up made the population size 
for the study. Patients lost during the follow up period 
were contacted by telephone. Data on patient status 
were obtained from their relatives and recorded ac-
cordingly. fifty-five CRC patients having baseline 
(preoperative) CEA levels were evaluated and fol-
lowed-up for a period of 2 years. Serum CEA level ≤5 
Fig. 2. Patient distribution according to carcinoembryonic antigen (CEA) levels.
Fig. 1. Sample characteristics: (a) gender distribution of patient population; (b) patient distribution by age; 
(c) patient distribution by disease grade (d); patient distribution by disease stage.
(a) (b)
(c) (d)
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ng/ml was considered normal, whereas levels above 
this value were considered elevated.
Data on the variables of interest, i.e. age, gender, 
stage and grade of tumor were collected and then cor-
related with serum CEA levels of patients using SPSS 
v. 16. The χ2-test was used for nonparametric analysis 
of categorical variables. Continuous variables includ-
ing age and preoperative CEA levels were dichoto-
mized into categorical variables, as follows: age >50 
and <50 years; and preoperative CEA levels <5 ng/ml 
considered normal and those >5 ng/ml considered 
raised for statistical analysis. Stage was also dichoto-
mized as early and late for calculating the risk estimate 
and correlation coefficient. Stage i and ii patients were 
grouped together as early, and stage iii termed as late 
stage patients.
Spearman coefficient (rho) was used to determine 
correlation coefficient. Risk estimates were calculated 
using 2×2 contingency tables and coordinates of the re-
ceiver operating characteristic (ROC) curve were used 
to assess sensitivity and specificity of the assay keeping 
recurrence as a state variable. likelihood  ratios were cal-
culated using the formula: lR+=sensitivity/1-specificity 
and lR-=1-sensitivity/specificity. The p values less than 
0.05 were considered significant.
Results
The present study comprised 55 patients with co-
lorectal adenocarcinoma of all operable stages. Demo-
graphic data are described in figure 1. The male to fe-
male ratio was 1.75:1.00. Preoperative serum CEA levels 
were found to be high in 76.4% (n=42, p<0.0001) and 
recurrence was observed in 32.7% (n=18) of patients.
normal CEA levels were significantly associated 
with no recurrence (p=0.008). Thirteen patients had 
normal preoperative CEA levels and recurrence was ob-
served in only two of them (fig. 2). Relative risk (RR) 
estimates were calculated for normal CEA levels and 
probability of non-recurrent disease. Patient population 
with normal preoperative CEA levels had 1.55-fold 
greater likelihood to develop no recurrence as compared 
to patients with raised initial CEA levels. These results 
were statistically significant (p=0.028) (Table 1).
On the other hand, raised preoperative CEA sig-
nificantly increased the risk of recurrence. The risk of 
disease recurrence was 5.26-fold greater in patients 
with raised initial CEA levels as compared to those 
with normal initial CEA levels (p=0.028). When cal-
culated for age, gender, stage and grade, RR did not 
reach statistical significance (Table 1).
We calculated correlation coefficients (rho) for 
overall raised preoperative CEA and recurrence. A sig-
nificant weak positive correlation (rs=0.297, p=0.028) 
was found between raised CEA and recurrence. When 
applied to the patient population aged <50, a highly 
significant (p=0.002) moderate positive relationship 
was found between raised CEA and recurrence 
(rs=0.471). in male patients, moderate positive correla-
tion of borderline significance (rs=0.324, p=0.058) was 
Table 1. Correlation between disease recurrence variables and raised carcinoembryonic antigen (CEA) levels using 
Spearman correlation coefficient (rs) and relative risk (RR)
variable Comparison type Correlation coefficient for CEA vs. recurrence Sig. (2-tailed)
RR of recurrence in 
raised CEA (95% Ci) Sig. (2-tailed)
Age (years) <50 (n=39) 0.471 0.002 nA -
>50 (n=16) -0.383 0.143 nA -
gender male (n=35) 0.324 0.058 4.40 (0.65-29.75) 0.056
female (n=20) 0.275 0.241 nA -
Stage Early (n=19) 0.218 0.370 2.30 (0.34-15.69) 0.342
late (n=36) 0.199 0.246 2.65 (0.40-17.28) 0.234
grade High (n=8) 0.000 1.000 1.00 (0.20-4.95) 1.00
low (n=47) 0.250 0.090 3.97 (0.58-27.05) 0.086
Overall (n=55) 0.297 0.028 5.26 (0.77-35.83) 0.028
normal CEA vs. no recurrence (RR) 1.55 (1.15-2.08) 0.028
nA = not assessed (due to less than expected counts in either category)
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found (Table 1). There was no significant correlation in 
the remaining parameters including age >50 years, 
 female patients, low/high grade and early/late stage 
(Table 1).
Coordinates of the ROC curve were used to deter-
mine sensitivity and specificity of preoperative CEA 
levels in predicting  recurrence. Keeping recurrence as 
positive actual state and considering serum CEA levels 
>5 ng/ml as raised, sensitivity of the marker was 
94.4% and specificity of the assay was 32.4% in pre-
dicting recurrence after curative resection.
in patients aged <50, a highly significant asso-
ciation was found between raised CEA and recurrence 
when calculating correlation coefficient. Sensitivity of 
the assay in predicting recurrence was 100%, with 
46.2% specificity in this group in concordance with 
the correlation coefficient. Sensitivity of the marker 
in predicting recurrence was low in early stage as 
 compared with late stage (83.3% vs. 91.7%). like-
lihood ratios (lR+ and lR-) were also calculated 
(Table 2).
The value of lR+ in the overall patient population 
was 1.39, showing that raised preoperative CEA min-
imally increased the likelihood of recurrence. On the 
other hand, lR- was 0.17 showing that normal preop-
erative CEA indicated moderate decrease in the likeli-
hood of recurrence.
Discussion
Colorectal carcinoma is the third most common 
cancer and has fatal outcome9. Preoperative CEA lev-
els have shown relationship with disease prognosis in 
CRC. many studies have reported strong association 
between raised CEA levels and recurrence (serum 
CEA levels >5 ng/ml are conventionally considered 
raised)10,11. Previous literature has reported that CEA 
is an independent prognostic factor for CRC. How-
ever, some recent studies have demonstrated that 
prognostic efficiency of the marker is not equal in all 
stages of the disease; there are opinions that 5 ng/ml 
may not be an optimal cut off for predicting recur-
rence. Prognostic value of normal preoperative CEA is 
also an unresolved question12-16.
Our study revealed that a significant patient popu-
lation with normal preoperative CEA levels had no 
disease recurrence (14 out of 16 cases free from recur-
rence, p=0.008). The RR of recurrence was also signifi-
cantly lower in this group (p=0.028) and patients with 
normal CEA had 1.55-fold lower risk of recurrence. 
The lower and upper borders with 95% confidence in-
tervals were close (95% Ci: 1.15-2.08) depicting pre-
cision as stated in Table 1.
in CRC, 30%-40% of patients are reported to have 
disease recurrence after curative resection17. in our 
study population, the rate of recurrence was 32.7% (18 
out of 55 patients). A recent study showed that 77% of 
CRC patients who experienced recurrence had raised 
preoperative CEA levels, while 32% had normal CEA. 
This percentage of study population with normal CEA 
having experienced recurrence was attributed to the 
fact that they may have had either early stage of tumor 
progression or a non-CEA producing tumor such as 
poorly differentiated carcinoma17.
in our study population, 88.9% of recurrences were 
recorded in patients with high preoperative CEA. 
Table 2. Sensitivity, specificity, positive and negative likelihood ratios (LR) of preoperative 
carcinoembryonic antigen in predicting recurrence
variable Comparison type Sensitivity (%) Specificity (%) lR+ lR-
Age (years) <50 (n=39) 100 46.2 1.85 -
>50 (n=16) 80.0 0 0.80 -
gender male (n=35) 91.7 39.1 1.50 0.21
female (n=20) 100 15.8 1.18 -
Stage Early (n=19) 83.3 38.5 1.35 0.43
late (n=36) 91.7 25.0 1.22 0.33
grade High (n=8) 75 25 1.0 1.0
low (n=47) 92.9 30.3 1.33 0.23
Overall (n=55) 94.4 32.4 1.39 0.17
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Only 11.1% of patients having recurrence had normal 
preoperative CEA levels. good correlation between 
CEA and recurrence is in concordance with literature 
data. in our patient population, there were 85.5% of 
well-differentiated (low-grade) tumors, which may 
have been the reason for better prognostic efficiency of 
the marker.
Correlation coefficient also supported the hypoth-
esis and rho was 0.00 in patients with high preopera-
tive CEA and recurrence. RR was also 1.00 showing 
no risk of recurrence in patients with elevated CEA 
having high-grade tumor. Patient population with 
low-grade (well-differentiated) tumor showed weak 
positive correlation between recurrence and raised pre-
operative CEA (rs=0.250); however, statistical signifi-
cance was not reached (p=0.090), maybe due to the 
small sample size (n=47). RR of recurrence in this 
group was also increased about 4 times (RR=3.97 
(0.58-27.05=; p=0.086) (Table 1).
Overall sensitivity of the raised preoperative CEA 
in predicting recurrence was 94.4% and specificity 
32.4%. Positive predictive value (PPv) and negative 
predictive value (nPv) was 38.0% and 84.6%, respec-
tively. The marker was found to have high overall sen-
sitivity but low specificity, and the false-positive rate 
was high. in the current study, out of 42 subjects with 
raised serum CEA levels, recurrence was recorded in 
16 (38.1%) cases. We recorded 61.9% (n=26) of false-
positive elevations of CEA in our study. Keeping the 
cut off of 7 ng/ml in a recent study, specificity of 
84.1% was achieved but sensitivity decreased to 36.4% 
in predicting recurrence. The PPv and nPv remained 
40.6% and 81.5%, respectively, which was close to our 
data (38.0% vs. 84.6%)18. low sensitivity of the marker 
was observed in early stage as compared to late stage 
(83.3% vs. 91.7%) (Table 2). These results are in con-
cordance with the literature and were attributed to low 
recurrence rate in early stage, thus increasing the false-
positive rate16.
negative and positive likelihood ratios were also 
calculated. generally, values >10 indicate large and 
 often conclusive increase in the likelihood of disease, 
and values 1-2 minimally increase the likelihood of 
disease. if the value is 1, it is indicative of no change in 
the likelihood of disease. values 0.5-1.0 indicate mini-
mal decrease in the likelihood of disease. values 0.2-
0.5 indicate small decrease, 0.1-0.2 moderate decrease, 
and <0.1 indicate large and often conclusive decrease 
in the likelihood of disease.
in our study population, the likelihood of recur-
rence ranged from 0.17 to 1.85 (Table 2). in the overall 
study population, lR+ was 1.39. So, it was inferred 
that raised preoperative CEA minimally increased the 
likelihood of recurrence. However, lR-, which was 
0.17, showed that normal preoperative CEA moder-
ately decreased the probability of recurrence. Our re-
sults favored the use of normal preoperative CEA in 
predicting nonrecurring disease more than the use of 
elevated preoperative CEA as a predictor of recur-
rence.
The best correlation of lR+ values (lR+ 1.85) was 
found in the <50 age group. in high-grade patients, no 
change in the likelihood of disease was inferred from 
the results (lR+ 1 and lR- 1).
There were some limitations in the present study 
including limited sample size, inadequate and incom-
plete patient records leading to omission of certain pa-
tients who might have been included in the analysis. 
moreover, an adequate control group of patients 
should be included in order to explore the role of se-
rum CEA in CRC prognosis.
Conclusions
A significant patient population (14 out of 16; 
p=0.008) with normal preoperative CEA levels were 
free from disease recurrence. RR of recurrence was 
1.55-fold lower in this group. Conversely, raised pre-
operative CEA significantly (5.26 times) increased the 
risk of recurrence as compared with those with normal 
CEA levels. in the patient population aged <50, a 
highly significant (p=0.002) moderate positive rela-
tionship was found between raised CEA and recur-
rence. Overall sensitivity of the raised preoperative 
CEA in predicting recurrence was 94.4% and specific-
ity, PPv and nPv were 32.4%, 38.0% and 84.6%, re-
spectively.
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Sažetak
ulOgA PRiJEOPERACiJSKOg KARCinOEmbRiJSKOg AnTigEnA  
u RECiDiviRAnJu RESEKTAbilnOg KOlOREKTAlnOg KARCinOmA
M. A. Khan, R. N. Maken, H. Nisar, .I Fatima, I. U. Khan, M. Masood i A. B. Shahid
u kolorektalnom karcinomu preporuča se karcinoembrijski antigen (CEA) kao biljeg u praćenju bolesnika nakon resek-
cije karcinoma. Cilj ovoga istraživanja bio je utvrditi udruženost prijeoperacijske razine CEA s recidiviranjem kolorektalnog 
karcinoma u našoj populaciji. u istraživanje je bilo uključeno 55 bolesnika sa svim operabilnim stadijima kolorektalnog 
adenokarcinoma liječenih u razdoblju od 2012. do 2014. godine. bolesnici su retrospektivno procijenjeni i praćeni zbog reci-
diva tijekom dvije godine. Podaci o bazalnim (prijeoperacijskim) razinama CEA preuzeti su iz medicinske dokumentacije 
bolesnika. Analiza podataka provedena je pomoću SPSS 16.0. Kod bolesnika s normalnom prijeoperacijskom razinom CEA 
stopa recidiva bila je značajno niža (p=0,008), a vjerojatnost izostanka recidiva 1,55 puta veća u usporedbi s bolesnicima s 
povišenim početnim razinama CEA (p=0,028). Kod bolesnika s povišenim prijeoperacijskim razinama CEA rizik od recidi-
va bio je 5,26 puta veći u usporedbi s onim u bolesnika s normalnim razinama CEA (p=0,028). Značajna slabo pozitivna 
korelacija (rs=0,297) utvrđena je između povišene razine CEA i recidiva. visoko značajna (p=0,002) umjereno pozitivna 
korelacija zabilježena je u bolesnika mlađih od 50 godina te umjereno pozitivna korelacija granične značajnosti kod muška-
raca (rs=0,324, p=0,058). utvrđena je osjetljivost od 94,4% i specifičnost od 32,4% u predviđanju recidiva. Dakle, povišena 
prijeopearcijska razina CEA pokazala je značajnu slabo pozitivnu korelaciju s recidivima, dok je normalna prijeoperacijska 
razina CEA umjereno snizila vjerojatnost recidiva.
Ključne riječi: Karcinoembrijski antigen; Kolorektalni karcinom; Prognoza; Recidiv; Rizik
